{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:15:42Z","timestamp":1773281742264,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1987,11,1]],"date-time":"1987-11-01T00:00:00Z","timestamp":562723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe\u2019s Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[1987,11]]},"DOI":"10.1007\/bf02334177","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T03:39:05Z","timestamp":1142393945000},"page":"461-464","source":"Crossref","is-referenced-by-count":13,"title":["Topical human fibroblast interferon for acute adenoviral conjunctivitis"],"prefix":"10.1007","volume":"225","author":[{"given":"K. R.","family":"Wilhelmus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. C.","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Herson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02334177_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9394(84)90125-9","volume":"98","author":"CP Adams Jr","year":"1984","unstructured":"Adams CP Jr, Cohen EJ, Albrecht J, Laibson PR (1984) Interferon treatment of adenoviral conjunctivitis. Am J Ophthalmol 98:429\u2013432","journal-title":"Am J Ophthalmol"},{"key":"BF02334177_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bjo.61.2.76","volume":"61","author":"S Darougar","year":"1977","unstructured":"Darougar S, Quinlan MP, Gibson JA, Jones BR, McSwiggan DA (1977) Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br J Ophthalmol 61:76\u201385","journal-title":"Br J Ophthalmol"},{"key":"BF02334177_CR3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bjo.53.8.530","volume":"53","author":"J Dudgeon","year":"1969","unstructured":"Dudgeon J, Bhargava SK, Ross CAC (1969) Treatment of adenovirus infection of the eye with 5-iodo-2\u2032-deoxyuridine. A double-blind trial. Br J Ophthalmol 53:530\u2013533","journal-title":"Br J Ophthalmol"},{"key":"BF02334177_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.epirev.a036264","volume":"5","author":"F Ederer","year":"1983","unstructured":"Ederer F (1983) Methodological problems in eye disease epidemiology. Epidemiol Rev 5: 51\u201366","journal-title":"Epidemiol Rev"},{"key":"BF02334177_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3181\/00379727-130-33506","volume":"130","author":"JG Gallagher","year":"1969","unstructured":"Gallagher JG, Khoobyarian N (1969) Adenovirus susceptibility to interferon: sensitivity of types 2, 7, and 12 to human interferon. Proc Soc Exp Biol Med 130:137\u2013142","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02334177_CR6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3181\/00379727-136-35395","volume":"136","author":"JG Gallagher","year":"1971","unstructured":"Gallagher JG, Khoobyarian N (1971) Sensitivity of adenovirus types 1, 3, 4, 5, 8, 11, and 18 to human interferon. Proc Soc Exp Biol Med 136:920\u2013924","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02334177_CR7","first-page":"133","volume":"94","author":"G de'Gennaro","year":"1982","unstructured":"de'Gennaro G, Gabai R (1982) Observations cliniques sur le traitement local des k\u00e9rato-conjunctivites virales par interf\u00e9ron leucocytaire et immunoglobulines. Bull Mem Soc Franc Ophthalmol 94:133\u2013136","journal-title":"Bull Mem Soc Franc Ophthalmol"},{"key":"BF02334177_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archopht.1965.00970030051012","volume":"73","author":"SD Hecht","year":"1965","unstructured":"Hecht SD, Hanna L, Sery TW, Jawetz E (1965) Treatment of epidemic keratoconjunctivitis with idoxuridine (IUDR). Arch Ophthalmol 73:49\u201354","journal-title":"Arch Ophthalmol"},{"key":"BF02334177_CR9","first-page":"498","volume":"19","author":"D Iki\u0107","year":"1981","unstructured":"Iki\u0107 D, Trajer D, Cupak K, Petricevi\u0107 I, Prazi\u0107 M, Soldo I, Jusi\u0107 D, Smerdel S, Soos E (1981) The clinical use of human leukocyte interferon in viral infections. Int J Clin Pharmacol Ther Toxicol 19:498\u2013505","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"BF02334177_CR10","first-page":"647","volume":"41","author":"J Imanishi","year":"1981","unstructured":"Imanishi J, Kishida T (1981) Clinical trials with interferon in Japan. Tex Rep Biol Med 41:647\u2013652","journal-title":"Tex Rep Biol Med"},{"key":"BF02334177_CR11","first-page":"959","volume":"19","author":"M Isacsohn","year":"1983","unstructured":"Isacsohn M, Berson B, Sternberg I, Morag A (1983) Human fibroblast interferon in treatment of viral diseases of the skin and mucous membranes. Isr J Med Sci 19:959\u2013962","journal-title":"Isr J Med Sci"},{"key":"BF02334177_CR12","first-page":"1668","volume":"33","author":"M Itoi","year":"1982","unstructured":"Itoi M (1982) The effect of human leukocyte interferon (alpha) on adenoviral conjunctivitis. A multicenter double-blind comparison. Ganka Ophthalmology 33:1668\u20131672","journal-title":"Ganka Ophthalmology"},{"key":"BF02334177_CR13","first-page":"212","volume":"11","author":"S Kitano","year":"1984","unstructured":"Kitano S (1984) Clinical trials of interferon in ophthalmology. Jpn J Cancer Chemother 11: 212\u2013220","journal-title":"Jpn J Cancer Chemother"},{"key":"BF02334177_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archopht.1970.00990040038010","volume":"84","author":"PR Laibson","year":"1970","unstructured":"Laibson PR, Dhiri S, Oconer J, Ortolan G (1970) Corneal infiltrates in epidemic keratoconjunctivitis. Response to double-blind corticosteroid therapy. Arch Ophthalmol 84:36\u201340","journal-title":"Arch Ophthalmol"},{"key":"BF02334177_CR15","first-page":"329","volume":"37","author":"N Laird","year":"1983","unstructured":"Laird N (1983) Further comparative analyses of pretest-post-test research design. Am Statistician 37:329\u2013330","journal-title":"Am Statistician"},{"key":"BF02334177_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/iai.29.3.995-998.1980","volume":"29","author":"MP Langford","year":"1980","unstructured":"Langford MP, Yin-Murphy M, Ho YM, Barber JC (1980) Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun 29: 995\u2013998","journal-title":"Infect Immun"},{"key":"BF02334177_CR17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.41.1.214-218.1983","volume":"41","author":"MP Langford","year":"1983","unstructured":"Langford MP, Villarreal AC, Stanton GJ (1983) Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection. Infect Immun 41: 214\u2013218","journal-title":"Infect Immun"},{"key":"BF02334177_CR18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3181\/00379727-127-32862","volume":"127","author":"JM Little","year":"1968","unstructured":"Little JM, Lorenzetti DWC, Brown DC, Schweem HH, Jones BR, Kaufman HE (1968) Studies of adenovirus type-III infection treated with methisazone and trifluorothymidine. Proc Soc Exp Biol Med 127:1028\u20131032","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02334177_CR19","first-page":"71","volume":"58","author":"YF Maichuk","year":"1981","unstructured":"Maichuk YF, Kouznetsov V (1981) New data on concentrated interferon in the treatment of viral eye diseases. Rev Int Trach Pathol Ocul Trop Subtrop 58:71\u201376","journal-title":"Rev Int Trach Pathol Ocul Trop Subtrop"},{"key":"BF02334177_CR20","first-page":"108","volume":"26","author":"Y Negoro","year":"1972","unstructured":"Negoro Y, Imanishi J, Kishida T, Hara K (1972) Prophylaxis of epidemic keratoconjunctivitis. Clin Ophthalmol 26:108\u2013110","journal-title":"Clin Ophthalmol"},{"key":"BF02334177_CR21","first-page":"125","volume":"24","author":"Y Negoro","year":"1980","unstructured":"Negoro Y, Imanishi J, Matsuo A, Kishida T (1980) Treatment of epidemic keratoconjunctivitis by human leukocyte interferon. Jpn J Ophthalmol 24:125\u2013127","journal-title":"Jpn J Ophthalmol"},{"key":"BF02334177_CR22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0002-9394(72)91130-0","volume":"74","author":"D Pavan-Langston","year":"1972","unstructured":"Pavan-Langston D, Dohlman CH (1972) A double-blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol 74:81\u201388","journal-title":"Am J Ophthalmol"},{"key":"BF02334177_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S0022172400066365","volume":"96","author":"S Reilly","year":"1986","unstructured":"Reilly S, Dhillon BJ, Nkanza KM, D'Souza AM, Taylor N, Hobbs SJ, Freke A, Roome AP (1986) Adenovirus type-8 keratoconjunctivitis \u2014 an outbreak and its treatment with topical human fibroblast interferon. J Hyg 96:557\u2013575","journal-title":"J Hyg"},{"key":"BF02334177_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/jir.1980.1.95","volume":"1","author":"A Romano","year":"1980","unstructured":"Romano A, Revel M, Guarari-Rotman D, Blumenthal M, Stein R (1980) Use of human fibroblast-derived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis. J Interferon Res 1:95\u2013100","journal-title":"J Interferon Res"},{"key":"BF02334177_CR25","first-page":"31","volume":"7","author":"A Romano","year":"1983","unstructured":"Romano A, Ladizensky E, Guarari-Rotman D, Revel M (1983) Clinical effect of human-fibroblast-derived (beta) interferon in treatment of adenovirus epidemic keratoconjunctivitis and its complication. Metab Pediatr Syst Ophthalmol 7:31\u201336","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"BF02334177_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02215650","volume":"218","author":"R Sundmacher","year":"1982","unstructured":"Sundmacher R, Wigand R, Cantell K (1982) The value of exogenous interferon in adenovirus keratoconjunctivitis. Preliminary results. Graefe's Arch Clin Exp Ophthalmol 218:139\u2013140","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF02334177_CR27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/jir.1982.2.401","volume":"2","author":"HR Thacore","year":"1982","unstructured":"Thacore HR, Mount DT, Chadha KC (1982) Interferon system of human cornea cells: interferon production, characterization, and development of antiviral state. J Interferon Res 2: 402\u2013408","journal-title":"J Interferon Res"},{"key":"BF02334177_CR28","first-page":"337","volume":"27","author":"M Toth","year":"1983","unstructured":"Toth M, Bakay M, Tarodi B, Toth S, Pusztai R, Beladi I (1983) Different interferon-inducing ability of human adenovirus types in chick embryo cells. Acta Virol 27:337\u2013345","journal-title":"Acta Virol"},{"key":"BF02334177_CR29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-2008-1057579","volume":"176","author":"S Trauzettel-Klosinski","year":"1980","unstructured":"Trauzettel-Klosinski S, Sundmacher R, Wigand R (1980) Die Wirkung von Steroiden bei Keratoconjunctivitis epidemica. Ergebnisse einer kontrollierten prospektiven Studie. Klin Monatsbl Augenheilkd 176:899\u2013906","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"BF02334177_CR30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0002-9394(76)90017-9","volume":"82","author":"GO Waring III","year":"1976","unstructured":"Waring III GO, Laibson PR, Satz JE, Joseph NH (1976) Use of vidarabine in epidemic keratoconjunctivitis due to adenovirus types 3, 7, 8, and 19. Am J Ophthalmol 82: 781\u2013785","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe\u2019s Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02334177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02334177\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02334177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T22:05:09Z","timestamp":1627164309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02334177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1987,11]]}},"alternative-id":["BF02334177"],"URL":"https:\/\/doi.org\/10.1007\/bf02334177","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,11]]}}}